Publicacions en col·laboració amb investigadors/es de Hospital Universitario La Fe (16)

2021

  1. Environmental exposure during pregnancy: Influence on prenatal development and early life: A comprehensive review

    Fetal Diagnosis and Therapy, Vol. 48, Núm. 4, pp. 245-257

2020

  1. The evolving microbiome from pregnancy to early infancy: A comprehensive review

    Nutrients, Vol. 12, Núm. 1

2019

  1. Chromatin regulation by Histone H4 acetylation at Lysine 16 during cell death and differentiation in the myeloid compartment

    Nucleic Acids Research, Vol. 47, Núm. 10, pp. 5016-5037

  2. Rationale and Study Design for an Individualized Perioperative Open Lung Ventilatory Strategy in Patients on One-Lung Ventilation (iPROVE-OLV)

    Journal of Cardiothoracic and Vascular Anesthesia, Vol. 33, Núm. 9, pp. 2492-2502

  3. Recommendations from a panel of experts on the usefulness of fidaxomicin for the treatment of infections caused by Clostridium difficile

    Revista Espanola de Quimioterapia, Vol. 32, Núm. 1, pp. 50-59

2018

  1. Biomarkers of oxidative stress derived damage to proteins and DNA in human breast milk

    Analytica Chimica Acta, Vol. 1016, pp. 78-85

  2. Individualised perioperative open-lung approach versus standard protective ventilation in abdominal surgery (iPROVE): a randomised controlled trial

    The Lancet Respiratory Medicine, Vol. 6, Núm. 3, pp. 193-203

  3. SDHC promoter methylation, a novel pathogenic mechanism in parasympathetic paragangliomas

    Journal of Clinical Endocrinology and Metabolism, Vol. 103, Núm. 1, pp. 295-305

2017

  1. Rationale and study design for an individualised perioperative open-lung ventilatory strategy with a high versus conventional inspiratory oxygen fraction (iPROVE-O2) and its effects on surgical site infection: Study protocol for a randomised controlled trial

    BMJ Open, Vol. 7, Núm. 7

2015

  1. Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial

    The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 785-792

  2. Rationale and study design for an individualized perioperative open lung ventilatory strategy (iPROVE): Study protocol for a randomized controlled trial

    Trials, Vol. 16, Núm. 1

2012

  1. Daidzein has neuroprotective effects through ligand-binding-independent PPARγ activation

    Neurochemistry International, Vol. 61, Núm. 1, pp. 119-127

2007

  1. Advances in lower respiratory tract infections in critically ill patients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. SUPPL. 1, pp. 47-57

  2. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)

    Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229

2002

  1. Profilaxia e tratamento da síndrome do desconforto respiratório com diferentes surfactantes

    Revista Brasileira de Medicina, Vol. 59, Núm. 3, pp. 172-176

2000

  1. Effects of vitamin A deficiency on mitochondrial function in rat liver and heart

    British Journal of Nutrition, Vol. 84, Núm. 6, pp. 927-934